These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8624695)

  • 1. Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation.
    Berardelli A; Rona S; Inghilleri M; Manfredi M
    Brain; 1996 Feb; 119 ( Pt 1)():71-7. PubMed ID: 8624695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor evoked responses to paired cortical magnetic stimulation in Parkinson's disease.
    Valzania F; Strafella AP; Quatrale R; Santangelo M; Tropeani A; Lucchi D; Tassinari CA; De Grandis D
    Electroencephalogr Clin Neurophysiol; 1997 Feb; 105(1):37-43. PubMed ID: 9118837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The excitability of human cortical inhibitory circuits responsible for the muscle silent period after transcranial brain stimulation.
    Bertasi V; Bertolasi L; Frasson E; Priori A
    Exp Brain Res; 2000 Jun; 132(3):384-9. PubMed ID: 10883387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical disinhibition in Parkinson's disease.
    Ammann C; Dileone M; Pagge C; Catanzaro V; Mata-Marín D; Hernández-Fernández F; Monje MHG; Sánchez-Ferro Á; Fernández-Rodríguez B; Gasca-Salas C; Máñez-Miró JU; Martínez-Fernández R; Vela-Desojo L; Alonso-Frech F; Oliviero A; Obeso JA; Foffani G
    Brain; 2020 Dec; 143(11):3408-3421. PubMed ID: 33141146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism.
    Priori A; Berardelli A; Inghilleri M; Accornero N; Manfredi M
    Brain; 1994 Apr; 117 ( Pt 2)():317-23. PubMed ID: 8186958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
    Buhmann C; Gorsler A; Bäumer T; Hidding U; Demiralay C; Hinkelmann K; Weiller C; Siebner HR; Münchau A
    Brain; 2004 Dec; 127(Pt 12):2732-46. PubMed ID: 15509619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease.
    Ridding MC; Inzelberg R; Rothwell JC
    Ann Neurol; 1995 Feb; 37(2):181-8. PubMed ID: 7847860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of motor cortical inhibition in patients with dystonia.
    Rona S; Berardelli A; Vacca L; Inghilleri M; Manfredi M
    Mov Disord; 1998 Jan; 13(1):118-24. PubMed ID: 9452336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracortical inhibition and facilitation are impaired in patients with early Parkinson's disease: a paired TMS study.
    Bares M; Kanovský P; Klajblová H; Rektor I
    Eur J Neurol; 2003 Jul; 10(4):385-9. PubMed ID: 12823490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired intracortical transmission in G2019S leucine rich-repeat kinase Parkinson patients.
    Ponzo V; Di Lorenzo F; Brusa L; Schirinzi T; Battistini S; Ricci C; Sambucci M; Caltagirone C; Koch G
    Mov Disord; 2017 May; 32(5):750-756. PubMed ID: 28186666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subthalamic stimulation modulates cortical motor network activity and synchronization in Parkinson's disease.
    Weiss D; Klotz R; Govindan RB; Scholten M; Naros G; Ramos-Murguialday A; Bunjes F; Meisner C; Plewnia C; Krüger R; Gharabaghi A
    Brain; 2015 Mar; 138(Pt 3):679-93. PubMed ID: 25558877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopaminergic treatment on functional cortico-cortical connectivity in Parkinson's disease.
    Zittel S; Heinbokel C; van der Vegt JP; Niessen E; Buhmann C; Gerloff C; Siebner HR; Münchau A; Bäumer T
    Exp Brain Res; 2015 Jan; 233(1):329-37. PubMed ID: 25300961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short and long latency afferent inhibition in Parkinson's disease.
    Sailer A; Molnar GF; Paradiso G; Gunraj CA; Lang AE; Chen R
    Brain; 2003 Aug; 126(Pt 8):1883-94. PubMed ID: 12805105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disturbed intracortical excitability in early Parkinson's disease is l-DOPA dose related: a prospective 12-month paired TMS study.
    Bares M; Kanovský P; Rektor I
    Parkinsonism Relat Disord; 2007 Dec; 13(8):489-94. PubMed ID: 17449315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of central motor functions using magnetic stimulation in Parkinson's disease.
    Diószeghy P; Hidasi E; Mechler F
    Electromyogr Clin Neurophysiol; 1999 Mar; 39(2):101-5. PubMed ID: 10207679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways mediating abnormal intracortical inhibition in Parkinson's disease.
    MacKinnon CD; Gilley EA; Weis-McNulty A; Simuni T
    Ann Neurol; 2005 Oct; 58(4):516-24. PubMed ID: 16178015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
    Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repetitive magnetic stimulation of cortical motor areas in Parkinson's disease: implications for the pathophysiology of cortical function.
    Gilio F; Currà A; Inghilleri M; Lorenzano C; Manfredi M; Berardelli A
    Mov Disord; 2002 May; 17(3):467-73. PubMed ID: 12112192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of carbamazepine on cortical excitatory and inhibitory phenomena: a study with paired transcranial magnetic stimulation.
    Schulze-Bonhage A; Knott H; Ferbert A
    Electroencephalogr Clin Neurophysiol; 1996 Sep; 99(3):267-73. PubMed ID: 8862116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
    Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
    Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.